Endocrinology

Lilly’s Oral GLP-1 Orforglipron Demonstrates Superiority in Phase 3 Diabetes Trials

Lilly’s Oral GLP-1 Orforglipron Demonstrates Superiorit...

Edusehat Februari 23, 2026 0 0

Eli Lilly’s “Ozempic-in-a-pill” candidate just cleared its most significant clin...

Compare and Contrast: As Glucagon-Like Peptide-1 Receptor Agonist Access Expands, Comparative Heart Outcomes Matter

Compare and Contrast: As Glucagon-Like Peptide-1 Recept...

Edusehat Februari 23, 2026 0 0

As the onslaught of anti-obesity drugs hit the market in recent years, more rese...

Beyond the Scale: What Else Glucagon-like Peptide-1 Receptor Agonists Can Do

Beyond the Scale: What Else Glucagon-like Peptide-1 Rec...

Edusehat Februari 23, 2026 0 0

In the United States, American Heart Month is observed in February to raise awar...

New Research Challenges Fears of Semaglutide-Linked Thyroid Cancer Risk

New Research Challenges Fears of Semaglutide-Linked Thy...

Edusehat Februari 23, 2026 0 0

The “black box” warning on the popular diabetes and weight loss drug semaglutide...

Both Ends of the Spectrum: Talking Obesity Science with Samuel Klein, MD

Both Ends of the Spectrum: Talking Obesity Science with...

Edusehat Februari 23, 2026 0 0

The Endocrine Society’s 2026 recipient of the Outstanding Clinical Investigator ...

Side Effects: Endocrine Society Journals Look at GLP-1RAs and the Positive and Negative Unintended Impacts

Side Effects: Endocrine Society Journals Look at GLP-1R...

Edusehat Februari 23, 2026 0 0

As the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) expands, so t...

Society Boosts Support for Researchers to Attend ENDO 2026 and Provides Career Development Opportunities

Society Boosts Support for Researchers to Attend ENDO 2...

Edusehat Februari 23, 2026 0 0

As an endocrine scientist and long-time Society member, I’m proud of the many pr...

7
8
9